How do you pay?

How to pay the least

Cash price

$500+ for 30 tablets

Pharmacies pay about this for Quviviq; you’d pay more.

  1. Ask your pharmacy for Quviviq’s cash price, and one or two other pharmacies too.
  2. Quviviq’s savings card works only with insurance from a job or one you bought.

No generic is sold yet.

Compare every option

Question
Brand nameQuviviq
Authorized genericdaridorexant
Regular genericdaridorexant
What you’d pay
At least$500for 30 tablets; pharmacies pay this
Not soldThere isn’t one
Not soldNone sold yet
Same as Quviviq?
The original
–
–

Brand nameThe maker’s card

QSavings Card

Savings card from Idorsia Pharmaceuticals

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $25 a month

Sign up on quviviq.com 

Or call 1-833-248-0021.

In the maker’s words

“Eligible commercially insured patients with a valid prescription for QUVIVIQ (daridorexant) 25 mg and 50 mg who present this savings card at participating pharmacies may pay as little as $0 for their first fill, and $25 for subsequent fills for a 30-day supply.”

From the maker’s offer on quviviq.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Quviviq itself, from the same company, sold without the brand name, and usually for less. For now Quviviq is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

QUVIVIQ is an orexin receptor antagonist indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.

Source: the FDA label for Quviviq (Idorsia Pharmaceuticals Ltd), February 26, 2026. Full label on DailyMed 

Good to know